2020
DOI: 10.2169/internalmedicine.2179-18
|View full text |Cite
|
Sign up to set email alerts
|

Successful Treatment of Amiodarone-induced Thyrotoxicosis Type 1 in Combination with Methimazole and Potassium Iodide in a Patient with Hashimoto's Thyroiditis

Abstract: A patient with underlying Hashimoto's thyroiditis developed amiodarone-induced thyrotoxicosis type 1 that was successfully treated using methimazole in combination with potassium iodide. A 35-year-old woman admitted for perinatal care of twin-to-twin transfusion syndrome was given amiodarone for 7 days for paroxysmal ventricular contraction following pulseless ventricular tachycardia 1 day after delivery. She developed thyrotoxicosis one month after the discontinuation of amiodarone therapy and was negative fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…According to a report, the median onset time of AIT from initiation of amiodarone therapy was 3.5 months for type 1 AIT (AIT due to excessive iodine-induced hormone synthesis), and 30 months for type 2 AIT (destructive thyroiditis due to the direct thyrotoxic effect of amiodarone) [31]. While there have been limited case reports suggesting AIT following short-term intravenous use [32,33], the causal relationship between shortterm intravenous amiodarone use and the onset or exacerbation of thyrotoxicosis has not been thoroughly investigated.…”
Section: Discussionmentioning
confidence: 99%
“…According to a report, the median onset time of AIT from initiation of amiodarone therapy was 3.5 months for type 1 AIT (AIT due to excessive iodine-induced hormone synthesis), and 30 months for type 2 AIT (destructive thyroiditis due to the direct thyrotoxic effect of amiodarone) [31]. While there have been limited case reports suggesting AIT following short-term intravenous use [32,33], the causal relationship between shortterm intravenous amiodarone use and the onset or exacerbation of thyrotoxicosis has not been thoroughly investigated.…”
Section: Discussionmentioning
confidence: 99%